Chongqing Ruibola Pharmaceutical Technology Co., Ltd.

Chongqing Angel Longxiang is a group company integrating R&D, production, sales, technology, and services. The company owns the following subsidiaries: Chongqing Angel Longxiang Pharmaceutical Co., Ltd., Chongqing Angel Longxiang Pharmaceutical Technology Co., Ltd., Chongqing Angel Longxiang Pharmaceutical Manufacturing Co., Ltd., Chongqing Jiayi Medical Devices Co., Ltd., and Jiangsu Angel Pharmaceutical Co., Ltd. The group headquarters is located in Erlang Overseas Students Science and Technology Entrepreneurship Park, Jiulongpo District, Chongqing, with total registered capital of 100 million yuan. The group possesses more than 40,000 square meters of modern and standardized business premises and production and R&D bases, and fully passed national GSP certification in December 2008, with annual sales of hundreds of millions of yuan.

As the group's R&D center, Chongqing Angel Longxiang Pharmaceutical Technology Co., Ltd. is located in Erlang Overseas Students Science and Technology Entrepreneurship Park, Chongqing. It is a modern standardized pharmaceutical R&D laboratory center covering 1,500 square meters, with capabilities ranging from laboratory-scale process research to kilogram-scale scale-up. The company has advanced instruments and equipment for API and pharmaceutical intermediate synthesis, formulation research, and quality stability studies, as well as a strong team for API and pharmaceutical intermediate synthesis and quality research. The company's current main research areas involve antitumor and cardiovascular drugs, and it is committed to the discovery and research of new drugs (including synthesis processes, formulation processes, and product quality research), custom synthesis of APIs or intermediates, technical services, technical consulting, and drug application registration.